Tier 3 · Filer Universe

Entrada Therapeutics, Inc.

TRDA · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$7.57
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001689375
Liquidity rank
#4016
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$25.42M2025-12-310001689375-26-000011
Annual diluted EPS-3.472025-12-310001689375-26-000011
Quarterly revenue$898,000.002026-06-300001689375-26-000054
Quarterly diluted EPS-1.012026-06-300001689375-26-000054

SEC EDGAR Frames batch generated 2026-08-23T22:53:06.992Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerISRG · Tier 1 peerHCA · Tier 1 peerAMGN · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames